ES2155783A1 - Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. - Google Patents

Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.

Info

Publication number
ES2155783A1
ES2155783A1 ES9901037A ES9901037A ES2155783A1 ES 2155783 A1 ES2155783 A1 ES 2155783A1 ES 9901037 A ES9901037 A ES 9901037A ES 9901037 A ES9901037 A ES 9901037A ES 2155783 A1 ES2155783 A1 ES 2155783A1
Authority
ES
Spain
Prior art keywords
preparation
temporarily
fermented milks
administrable
orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9901037A
Other languages
English (en)
Other versions
ES2155783B1 (es
Inventor
Amat Pere Pujol
Eric Pospaire
Guardia Jose Antonio Mateos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danone SA Spain
Original Assignee
Danone SA Spain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009901037A priority Critical patent/ES2155783B1/es
Application filed by Danone SA Spain filed Critical Danone SA Spain
Priority to AT00935083T priority patent/ATE291353T1/de
Priority to DE60018919T priority patent/DE60018919T2/de
Priority to AU50695/00A priority patent/AU5069500A/en
Priority to PCT/EP2000/004593 priority patent/WO2000067583A2/en
Priority to PT00935083T priority patent/PT1178730E/pt
Priority to EP00935083A priority patent/EP1178730B1/en
Priority to DK00935083T priority patent/DK1178730T3/da
Priority to ES00935083T priority patent/ES2238285T3/es
Priority to MXPA01011336A priority patent/MXPA01011336A/es
Publication of ES2155783A1 publication Critical patent/ES2155783A1/es
Application granted granted Critical
Publication of ES2155783B1 publication Critical patent/ES2155783B1/es
Priority to ES200300009A priority patent/ES2209660B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

Nueva utilización de Lactobacillus casei para la preparación de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. Utilización de Lactobacillus casei para la preparación de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos de forma transitoria en individuos sometidos a estrés fisiológico con un contenido de Lactobacillus casei superior a 1 x 10{sup,5} ufc por mililitro.
ES009901037A 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. Expired - Fee Related ES2155783B1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES009901037A ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES00935083T ES2238285T3 (es) 1999-05-07 2000-05-05 Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos.
AU50695/00A AU5069500A (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
PCT/EP2000/004593 WO2000067583A2 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
PT00935083T PT1178730E (pt) 1999-05-07 2000-05-05 Utilizacao de bacterias do acido lactico na preparacao de leites fermemntados para o tratamento de niveis de imunidade deprimidos
EP00935083A EP1178730B1 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
AT00935083T ATE291353T1 (de) 1999-05-07 2000-05-05 Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
DE60018919T DE60018919T2 (de) 1999-05-07 2000-05-05 Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
MXPA01011336A MXPA01011336A (es) 1999-05-07 2000-05-05 Uso de bacterias de acido lactico en la preparacion de leches fermentadas para el tratamiento de los niveles deprimidos de inmunidad.
DK00935083T DK1178730T3 (da) 1999-05-07 2000-05-05 Anvendelse af mælkesyrebakterier til fremstilling af fermenterede mælkeprodukter til behandling af svækkede immunitetsniveauer
ES200300009A ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901037A ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.

Publications (2)

Publication Number Publication Date
ES2155783A1 true ES2155783A1 (es) 2001-05-16
ES2155783B1 ES2155783B1 (es) 2002-05-16

Family

ID=8308411

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009901037A Expired - Fee Related ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES200300009A Expired - Fee Related ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES200300009A Expired - Fee Related ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Country Status (1)

Country Link
ES (2) ES2155783B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023727A1 (en) * 1996-11-29 1998-06-04 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
WO1999010476A1 (en) * 1997-08-21 1999-03-04 New Zealand Dairy Board Immunity enhancing lactic acid bacteria

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023727A1 (en) * 1996-11-29 1998-06-04 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
WO1999010476A1 (en) * 1997-08-21 1999-03-04 New Zealand Dairy Board Immunity enhancing lactic acid bacteria

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
OUWEHAND A C et al.: "The health effects of cultured milk products with viable and non-viable bacteria". INTERNATIONAL DAIRY JOURNAL 8 (9) 749-758, 1998. Pagina 749, columna 1; pagina 751, columna 1. *
PERDIGON G et al.: "PREVENTION OF GASTROINTESTINAL INFECTION USING IMMUNOBIOLOGICAL METHODS WITH MILK FERMENTED WITH LACTOBACILLUS CASEI AND LACTOBACILLUS ACIDOPHILUS". JOURNAL DAIRY RESEARCH, CAMBRIDGE, GB, Vol. 57, 1990, paginas 255-264, XP000916913. Paginas 255-256. *
PERDIGON G. et al.: Systemic and Local augmentation of the Immune Response in Mice by feeding with milk fermented with Lactobacillus acidophilus and/or Lactobacillus casei". Foods, Nutrition and Immunity. Dyn Nut Res., Basel, Karger, 1992, Vol. 1, paginas 66-77. Paginas 66,67. *
SALJI J: "Acidophilus milk products: foods with a third dimension". FOOD SCIENCE & TECHNOLOGY TODAY 1992 45 PURBECK CLOSE, BEDFORD MK41 9LX, UK, Vol. 6, no 3, paginas 142-147, XP000952420. Pagina 146; tabla 2. *

Also Published As

Publication number Publication date
ES2155783B1 (es) 2002-05-16
ES2209660B1 (es) 2005-04-01
ES2209660A1 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
CA2271930C (en) Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
Presterl et al. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion?
WO2000071138A3 (en) Oral administration of lactobacillus for the maintenance of health in women
GB0124580D0 (en) New composition
RU2000106746A (ru) Молочнокислые бактерии, усиливающие иммунитет
NZ337520A (en) biological culture of L. rhamnosus and compositions useful in immunity enhancement
DE602004005029D1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
PL356459A1 (en) Somnogenic activity of non-pathogenic lactic acid bacteria
EP1325749A4 (en) AGENT ENHANCING BONE METABOLISM
CN108576223A (zh) 一种成人用益生菌固体饮料配方
ES2155783A1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
WO2004001020A3 (en) Methods and means to promote gut absorption
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
ES2155782A1 (es) Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
RU93036410A (ru) Сухой пробиотик для жвачных животных "руменолакт"
BG100678A (en) Low lactose dietetic milk product and method for its preparation
Terada et al. Effect of yoghurt consumption on fecal flora and fecal metabolites in healthy adults
RU93011197A (ru) Препарат, способствующий адаптации организма к неблагоприятным внешним воздействиям, бактериальная закваска для его получения и напитки на ее основе
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
周小平 et al. Treatment of neurofibromatosis with Chinese herbal drugs
Kasimova et al. Microbiological characteristics of diphtheria cultures circulating in Azerbaijan.
MXPA99004976A (es) Fermento láctico que comprende una cepa particular de lactobacillus acidophilus y el uso de la misma

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516

FD2A Announcement of lapse in spain

Effective date: 20190520

FD2A Announcement of lapse in spain

Effective date: 20190603